CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,300 | $41.99 | $139K | 194,378 |
| 2018-04-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,100 | $42.60 | $47K | 193,278 |
| 2018-04-12 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,200 | $42.63 | $136K | 198,878 |
| 2018-04-12 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,200 | $43.69 | $52K | 197,678 |
| 2018-04-11 | Ciechanover Isaac E. Chief Executive Officer | Sale | −4,000 | $40.77 | $163K | 202,478 |
| 2018-04-11 | Ciechanover Isaac E. Chief Executive Officer | Sale | −400 | $41.37 | $17K | 202,078 |
| 2018-04-09 | Kim Mina Senior VP & General Counsel | Grant or award | +42,500 | 42,500 | ||
| 2018-04-09 | Kim Mina Senior VP & General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2018-04-03 | Newell Joe Chief Tech. Operations Officer | Shares withheld for taxes | −642 | $36.25 | $23K | 31,858 |
| 2018-03-29 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −22,400 | $40.07 | $898K | 133,671 |
| 2018-03-27 | Ciechanover Isaac E. Chief Executive Officer | Sale | −200 | $38.40 | $8K | 206,478 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Option exercise | +28,848 | $25.15 | $726K | 212,368 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Option exercise | +32,500 | $22.72 | $738K | 244,868 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Option exercise | +11,406 | $11.00 | $125K | 256,274 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −22,794 | $36.43 | $830K | 233,480 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −31,356 | $37.10 | $1.2M | 202,124 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −29,980 | $38.23 | $1.1M | 172,144 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −2,170 | $39.53 | $86K | 169,974 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −2,800 | $40.40 | $113K | 167,174 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −11,103 | $41.10 | $456K | 156,071 |
Page 32 of 44 · 867 trades